Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A role of antifibrotics in the treatment of Scleroderma-ILD?
Antoniou KM, Trachalaki A, Tzouvelekis A, Poletti V, Vasarmidi E, Sfikakis P, Bouros D. Antoniou KM, et al. Among authors: poletti v. Pulmonology. 2020 Jan-Feb;26(1):1-2. doi: 10.1016/j.pulmoe.2019.08.004. Epub 2019 Oct 23. Pulmonology. 2020. PMID: 31653592 Free article. Review. No abstract available.
Interstitial lung disease.
Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V. Antoniou KM, et al. Among authors: poletti v. Eur Respir Rev. 2014 Mar 1;23(131):40-54. doi: 10.1183/09059180.00009113. Eur Respir Rev. 2014. PMID: 24591661 Free PMC article. Review.
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
Wuyts WA, Antoniou KM, Borensztajn K, Costabel U, Cottin V, Crestani B, Grutters JC, Maher TM, Poletti V, Richeldi L, Vancheri C, Wells AU. Wuyts WA, et al. Among authors: poletti v. Lancet Respir Med. 2014 Nov;2(11):933-942. doi: 10.1016/S2213-2600(14)70232-2. Epub 2014 Nov 3. Lancet Respir Med. 2014. PMID: 25439569 Review.
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.
Schiza S, Mermigkis C, Margaritopoulos GA, Daniil Z, Harari S, Poletti V, Renzoni EA, Torre O, Visca D, Bouloukaki I, Sourvinos G, Antoniou KM. Schiza S, et al. Among authors: poletti v. Eur Respir Rev. 2015 Jun;24(136):327-39. doi: 10.1183/16000617.00009114. Eur Respir Rev. 2015. PMID: 26028644 Free PMC article. Review.
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group. Johannson KA, et al. Lancet Respir Med. 2017 Jul;5(7):591-598. doi: 10.1016/S2213-2600(17)30219-9. Lancet Respir Med. 2017. PMID: 28664861 Review.
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.
Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium. Walsh SLF, et al. Among authors: poletti v. Eur Respir J. 2017 Aug 31;50(2):1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28860269 Free article.
Assembly 12: interstitial lung diseases.
Antoniou K, Trachalaki A, Bibaki E, Poletti V. Antoniou K, et al. Among authors: poletti v. Breathe (Sheff). 2018 Dec;14(4):345-346. doi: 10.1183/20734735.026518. Breathe (Sheff). 2018. PMID: 30519306 Free PMC article.
Research highlights from the 2018 ERS International Congress: interstitial lung diseases.
Alfaro TM, Moor CC, Alfieri V, Jeny F, Kreuter M, Wijsenbeek MS, Renzoni EA, Bargagli E, Nunes H, Spagnolo P, Bonella F, Molina-Molina M, Antoniou K, Poletti V. Alfaro TM, et al. Among authors: poletti v. ERJ Open Res. 2019 Feb 18;5(1):00215-2018. doi: 10.1183/23120541.00215-2018. eCollection 2019 Feb. ERJ Open Res. 2019. PMID: 30792985 Free PMC article. Review.
Pulmonary fibrosis: "idiopathic" is not "cryptogenic".
Wells AU, Brown KK, Flaherty KR, Kolb M, Thannickal VJ; IPF Consensus Working Group; IPF Consensus Working Group:. Wells AU, et al. Eur Respir J. 2019 Mar 18;53(3):1900400. doi: 10.1183/13993003.00400-2019. Print 2019 Mar. Eur Respir J. 2019. PMID: 30886028 Free article. No abstract available.
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.
Walsh SLF, Lederer DJ, Ryerson CJ, Kolb M, Maher TM, Nusser R, Poletti V, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown KK, Corte TJ, Cottin V, Crestani B, Flaherty KR, Glaspole IN, Grutters J, Inoue Y, Kondoh Y, Kreuter M, Johannson KA, Ley B, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts WA, Wells AU. Walsh SLF, et al. Among authors: poletti v. Am J Respir Crit Care Med. 2019 Nov 1;200(9):1146-1153. doi: 10.1164/rccm.201903-0493OC. Am J Respir Crit Care Med. 2019. PMID: 31241357 Free article.
427 results